Sodium Bicarbonate Injection, USP by Hospira: Recall - Particulate Matter

Administration of product with particulates may result in localized inflammation, allergic reaction including anaphylaxis, granuloma formation, microembolic effects, or delay of therapy.
Source: FDA MedWatch Safety Alert - Category: American Health Source Type: alerts